rxstat › Shortages › Ifosfamide
Ifosfamide shortage status
Widespread shortage Tier 3: critical
Source: Health Canada shortage reports · Updated Jul 9, 2026
Ifosfamide is in a widespread shortage in Canada. 2 of 2 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. The latest manufacturer estimate for full recovery is Sep 30, 2026.
In shortage since
Dec 19, 2025
Est. full return
Sep 30, 2026
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageIFEX
1G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241357 · since Dec 19, 2025, est. end Sep 30, 2026 · Shortage of an active ingredient.
Active shortageIFEX
3G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241356 · since Dec 19, 2025, est. end Sep 30, 2026 · Shortage of an active ingredient.
ResolvedIFEX
1G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241357 · ended Oct 9, 2023 · Delay in shipping of the drug.
ResolvedIFEX
1G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241357 · ended Sep 1, 2020 · Delay in shipping of the drug.
ResolvedIFEX
3G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241356 · ended Jun 22, 2020 · Delay in shipping of the drug.
ResolvedIFEX
1G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241357 · ended May 12, 2020 · Delay in shipping of the drug.
ResolvedIFEX (IFOSFAMIDE) 3 G/VIAL
3G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241356 · ended Apr 20, 2020 · Delay in shipping of the drug.
ResolvedIFEX (IFOSFAMIDE) 3 G/VIAL
3G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241356 · ended Feb 4, 2020 · Delay in shipping of the drug.
ResolvedIFEX (IFOSFAMIDE) 3 G/VIAL
3G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241356 · ended Feb 4, 2019 · Demand increase for the drug.
ResolvedIFEX (IFOSFAMIDE) 1 G/VIAL
1G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241357 · ended Oct 5, 2017 · Demand increase for the drug.
ResolvedIFEX (IFOSFAMIDE) 1 G/VIAL
1G · POWDER FOR SOLUTION · BAXTER CORPORATION
DIN 02241357 · ended Jun 12, 2017 · Demand increase for the drug.
What's happening
Ifosfamide is currently affected by 2 active shortage reports filed with Health Canada by BAXTER CORPORATION.
The reported cause is: shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ifosfamide is classified under “ALKYLATINGAGENTS” (ATC L01AA).
Recent changes
Common questions
When will Ifosfamide be back in stock in Canada?
The latest manufacturer estimate is Sep 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Ifosfamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All alkylatingagents shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.